Filtered By:
Specialty: Cancer & Oncology
Condition: Hemorrhagic Stroke

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 62 results found since Jan 2013.

The Gut Microbiota-Brain Axis in Acute Neurological Disease: Focus on Stroke
Rev Recent Clin Trials. 2022 Mar 21. doi: 10.2174/1574887117666220321155508. Online ahead of print.ABSTRACTThe gut microbiota is one of the great innovations of modern medicine. In the modern microbiota revolution era, more comprehensive and in-depth studies have been performed as regards the microbial gut communities and their impact on acute and chronic diseases, including those of the nervous system as acute neurological diseases. The microbiota has changed our knowledge of medical conditions; in particular, considering stroke (both ischemic and hemorrhagic), literature studies, experimental and clinical researches indi...
Source: Reviews on Recent Clinical Trials - March 23, 2022 Category: Cancer & Oncology Authors: Saviano Angela Gayani Gunawardena Zanza Christian Longhitano Yaroslava Migneco Alessio Candelli Marcello Franceschi Francesco Ojetti Veronica Source Type: research

Sleep duration and risk of stroke and coronary heart disease: a 9-year community-based prospective study of 0.5 million Chinese adults
CONCLUSIONS: While abnormal sleep duration (≤ 6 h or ≥ 9 h) was associated with higher risks of CVD, the risks were more extreme for those reporting ≤ 5 or ≥ 10 h, respectively and such individuals should be prioritised for more intensive treatment for CVD prevention.PMID:37710209 | DOI:10.1186/s12883-023-03367-4
Source: Cancer Control - September 14, 2023 Category: Cancer & Oncology Authors: Yiping Chen Christiana Kartsonaki Robert Clarke Yu Guo Huaidong Du Canqing Yu Ling Yang Pei Pei Rebecca Stevens Sushila Burgess Yujie Hua Junshi Chen Jun Lv Liming Li Zhengming Chen China Kadoorie Biobank Collaborative Group Source Type: research

Rare stroke mechanisms in 4154 consecutive patients: causes, predictors, treatment, and outcomes
CONCLUSIONS: RMS occurred in 5.3% of a large population of consecutive AISs and are most frequently related to medical interventions, cancer, and vasculitis. RMS patients have less traditional risk factors but more systemic comorbidities, hemorrhagic transformations, recurrences, and a worse long-term outcome. Identification of RMS has direct implications for early treatment and long-term outcome.PMID:35994133 | DOI:10.1007/s10072-022-06344-w
Source: Cancer Control - August 22, 2022 Category: Cancer & Oncology Authors: Alex Vicino Gaia Sirimarco Ashraf Eskandari Dimitris Lambrou Philippe Maeder Vincent Dunet Patrik Michel Source Type: research

Predictors of unknown cancer in patients with ischemic stroke
AbstractStroke is the second most frequent neurologic finding in postmortem studies of cancer patients. It has also been described as the first expression of an occult cancer. We have studied patients diagnosed with cancer after an ischemic stroke (IS) and we analyze differences with non-tumor patients. Single cohort longitudinal retrospective study of patients admitted to our center with IS diagnosis from 1 January 2012 to 12 December 2014. All patients were followed for 18  months. Patients with transient ischemic infarction or cerebral hemorrhage, active cancer or in the last 5 years, inability to follow-up or absence...
Source: Journal of Neuro-Oncology - January 8, 2018 Category: Cancer & Oncology Source Type: research

Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial
This study has been approved by the National Ethics Committee (IDRCB:2019-A01543-54/SI:19.06.21.40640). ClinicalTrials.gov NCT04053166.PMID:35164816 | DOI:10.1186/s13063-022-06061-x
Source: Cancer Control - February 15, 2022 Category: Cancer & Oncology Authors: Mathilde Mura Emeraude Rivoire Leila Dehina-Khenniche Mich èle Weiss-Gayet B énédicte Chazaud Camille Faes Philippe Connes Anne Long Chantal L Rytz Pauline Mury Lidia Delrieu Etienne Gouraud Marine Bordet Nellie Della Schiava Patrick Lermusiaux Matthie Source Type: research

Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab
AbstractBevacizumab (BVZ), a monoclonal antibody directed against vascular endothelial growth factor (VEGF), has been suspected to increase the incidence of ischemic stroke (IS) and intracranial hemorrhage (ICH) in GBM patients. Intracranial vascular events, such as IS and ICH, were retrospectively analyzed in 364 MRI scans of 82 patients with recurrent GBM (1st/2nd/3rd relapse). Out of these 82 patients, 40 were treated with BVZ (178 scans) in addition to basic treatment, whereas 42 patients matching for age and gender received basic treatment (186 scans). Distribution of typical vascular risk factors between both groups ...
Source: Journal of Neuro-Oncology - May 29, 2017 Category: Cancer & Oncology Source Type: research

Radioiodine Therapy for Thyroid Cancer Doesn ’ t Up Stroke Risk
I - 131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke
Source: The Doctors Lounge - Oncology - August 19, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Neurology, Oncology, ENT, Radiology, Journal, Source Type: news

Endovascular therapy for acute ischemic stroke in patients with active malignancy: a meta-analysis with trial sequential analysis
CONCLUSION: Although a quarter of patients with active malignancy and AIS regained functional independence, physicians and patients should consider whether to apply EVT in patients with active malignancy.PMID:36163348 | DOI:10.1136/jnis-2022-019489
Source: Cancer Control - September 26, 2022 Category: Cancer & Oncology Authors: Hong-Jie Jhou Li-Yu Yang Po-Huang Chen Cho-Hao Lee Source Type: research

Cn-20 * bevacizumab causing recurrent cerebral infarction in a patient with glioblastoma: a previously undocumented phenomenon
CONCLUSIONS: Here we describe a case of an ischemic stroke with radiographic correlate while on bevacizumab, with clinical improvement arrested by the development of a recurrent stroke when bevacizumab was restarted. Interestingly, the distal arteries within the stroke bed appeared somewhat attentuated, suggestive of radiation vasculopathy. This case, describing a previously undocumented phenomenon, raises the possibility of a synergistic effect of bevacizumab and radiation vasculopathy. It may be that radiation vasculoapthy alone is typically insufficient to cause ischemia, but the addition of bevacizumab may precipitate ...
Source: Neuro-Oncology - November 3, 2014 Category: Cancer & Oncology Authors: Winkel, D., Voloschin, A. Tags: COMPLICATIONS OF THERAPY AND NEUROTOXICITY Source Type: research

Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
Authors: Thériault P, Le Béhot A, ElAli A, Rivest S Abstract Stroke is associated with neuroinflammation, neuronal loss and blood-brain barrier (BBB) breakdown. Thus far, recombinant tissue-type plasminogen activator (rtPA), the only approved treatment for acute ischemic stroke, increases the risk of intracerebral hemorrhage and is poorly efficient in disaggregating platelet-rich thrombi. Therefore, the development of safer and more efficient therapies is highly awaited. Encouraging neuroprotective effects were reported in mouse models of ischemic stroke following administration of erythropoietin (EPO). However, ...
Source: Oncotarget - June 2, 2016 Category: Cancer & Oncology Tags: Oncotarget Source Type: research

Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis
CONCLUSIONS: Stroke prevalence is increased in long-surviving PBT patients treated with cranial RT.IMPLICATIONS FOR CANCER SURVIVORS: CV events are frequent in long survivors of PBT treated with cerebral RT. We propose a check list to guide management of late CV complications in adults treated with RT for PBT.PMID:37142871 | DOI:10.1007/s11764-023-01350-z
Source: Cancer Control - May 4, 2023 Category: Cancer & Oncology Authors: Mar ía-José Ibáñez-Juliá Alberto Picca Delphine Leclercq Giulia Berzero Julian Jacob Lo ïc Feuvret Charlotte Rosso Cristina Birzu Agusti Alentorn Marc Sanson Camille Tafani Flavie Bompaire Luis Bataller Kh ê Hoang-Xuan Jean-Yves Delattre Dimitri Ps Source Type: research

The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease
Sickle cell disease (SCD) is complicated by neurologic complications including vasculopathy, hemorrhagic or ischemic overt stroke, silent cerebral infarcts and cognitive dysfunction. Patients with SCD, even in the absence of vasculopathy or stroke, have experience cognitive dysfunction that progresses with age. Transcranial Doppler ultrasound and structural brain MRI are currently used for primary and secondary stroke prevention, but laboratory or imaging biomarkers do not currently exist that are specific to the risk of cognitive dysfunction in patients with SCD. Recent investigations have used advanced MR sequences asses...
Source: Hematology/Oncology Clinics of North America - November 16, 2022 Category: Cancer & Oncology Authors: Kristie Ramos, Kristin P. Guilliams, Melanie E. Fields Source Type: research

Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage
In conclusion, microbiome-related metabolites in ICH patients was associated with the severity of ICH, the microbiota-host co-metabolites may be a potential may be potential therapeutic targets.PMID:36619742 | PMC:PMC9813413 | DOI:10.3389/fcimb.2022.999627
Source: Cancer Control - January 9, 2023 Category: Cancer & Oncology Authors: Lei Chen Sai Wang Yupeng Zhang Ye Li Xiangbin Zhang Junyi Ma Xuelun Zou TianXing Yao Si Li Junyou Chen Huifang Zhou Lianxu Wu Yanhong Zhou Le Zhang Source Type: research